Minimal genome-wide human CRISPR-Cas9 library.


Journal

Genome biology
ISSN: 1474-760X
Titre abrégé: Genome Biol
Pays: England
ID NLM: 100960660

Informations de publication

Date de publication:
21 01 2021
Historique:
received: 08 05 2020
accepted: 07 01 2021
entrez: 22 1 2021
pubmed: 23 1 2021
medline: 15 12 2021
Statut: epublish

Résumé

CRISPR guide RNA libraries have been iteratively improved to provide increasingly efficient reagents, although their large size is a barrier for many applications. We design an optimised minimal genome-wide human CRISPR-Cas9 library (MinLibCas9) by mining existing large-scale gene loss-of-function datasets, resulting in a greater than 42% reduction in size compared to other CRISPR-Cas9 libraries while preserving assay sensitivity and specificity. MinLibCas9 provides backward compatibility with existing datasets, increases the dynamic range of CRISPR-Cas9 screens and extends their application to complex models and assays.

Identifiants

pubmed: 33478580
doi: 10.1186/s13059-021-02268-4
pii: 10.1186/s13059-021-02268-4
pmc: PMC7818936
doi:

Substances chimiques

RNA, Guide 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

40

Subventions

Organisme : Wellcome Trust
ID : 206194
Pays : United Kingdom

Références

Nucleic Acids Res. 2019 Jan 8;47(D1):D427-D432
pubmed: 30357350
Genome Biol. 2016 Jul 05;17(1):148
pubmed: 27380939
Cell. 2016 Dec 15;167(7):1853-1866.e17
pubmed: 27984732
Nature. 2019 Apr;568(7753):511-516
pubmed: 30971826
Nat Genet. 2017 Feb;49(2):193-203
pubmed: 27992415
Cell Rep. 2015 Jul 28;12(4):673-83
pubmed: 26190106
Cell. 2015 Dec 3;163(6):1515-26
pubmed: 26627737
Cell. 2016 Dec 15;167(7):1867-1882.e21
pubmed: 27984733
Nat Biotechnol. 2015 Jun;33(6):661-7
pubmed: 25961408
BMC Bioinformatics. 2016 Apr 16;17:164
pubmed: 27083490
Elife. 2016 Mar 17;5:
pubmed: 26987018
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
Nat Biotechnol. 2018 Nov 27;:
pubmed: 30480667
BMC Genomics. 2018 Aug 13;19(1):604
pubmed: 30103702
G3 (Bethesda). 2017 Aug 7;7(8):2719-2727
pubmed: 28655737
Nat Biotechnol. 2016 Feb;34(2):184-191
pubmed: 26780180
Nat Biotechnol. 2014 Mar;32(3):267-73
pubmed: 24535568
Bioinformatics. 2014 May 15;30(10):1473-5
pubmed: 24463181
Nat Biotechnol. 2013 Sep;31(9):827-32
pubmed: 23873081
Science. 2015 Nov 27;350(6264):1096-101
pubmed: 26472758
Nat Commun. 2019 Dec 20;10(1):5817
pubmed: 31862961
Cell Rep. 2016 Oct 18;17(4):1193-1205
pubmed: 27760321
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
BMC Biol. 2020 Nov 23;18(1):174
pubmed: 33228647
Nat Commun. 2018 Jul 30;9(1):2983
pubmed: 30061675
Cancer Discov. 2016 Aug;6(8):914-29
pubmed: 27260156
Nat Commun. 2018 Dec 21;9(1):5416
pubmed: 30575746
Mol Ther Nucleic Acids. 2018 Mar 2;10:36-44
pubmed: 29499947
Nucleic Acids Res. 2017 Jan 4;45(D1):D619-D625
pubmed: 27799471
Nat Biotechnol. 2014 Dec;32(12):1262-7
pubmed: 25184501
Nat Methods. 2015 Oct;12(10):982-8
pubmed: 26322839
Nat Protoc. 2017 Apr;12(4):828-863
pubmed: 28333914
Nat Commun. 2020 Feb 6;11(1):752
pubmed: 32029722
Genome Res. 2019 Mar;29(3):464-471
pubmed: 30674557
Nat Methods. 2014 Aug;11(8):783-784
pubmed: 25075903
Nucleic Acids Res. 2013 Jan;41(Database issue):D955-61
pubmed: 23180760
Science. 2014 Jan 3;343(6166):80-4
pubmed: 24336569
Nat Biotechnol. 2021 Jan;39(1):94-104
pubmed: 32661438
Genome Biol. 2019 Feb 5;20(1):27
pubmed: 30722791
Science. 2012 Aug 17;337(6096):816-21
pubmed: 22745249
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
Cancer Discov. 2016 Aug;6(8):900-13
pubmed: 27260157
Nature. 2012 Mar 28;483(7391):570-5
pubmed: 22460902
Nat Commun. 2019 Jul 17;10(1):3144
pubmed: 31316073
Bioinformatics. 2015 Sep 15;31(18):3078-80
pubmed: 25979474
Cell. 2016 Jul 28;166(3):740-754
pubmed: 27397505

Auteurs

Emanuel Gonçalves (E)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Mark Thomas (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Fiona M Behan (FM)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Gabriele Picco (G)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Clare Pacini (C)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Open Targets, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.

Felicity Allen (F)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Alessandro Vinceti (A)

Human Technopole, Via Cristina Belgioioso 147, 20157, Milan, Italy.

Mamta Sharma (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

David A Jackson (DA)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Stacey Price (S)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Charlotte M Beaver (CM)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Oliver Dovey (O)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

David Parry-Smith (D)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.

Francesco Iorio (F)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Human Technopole, Via Cristina Belgioioso 147, 20157, Milan, Italy.

Leopold Parts (L)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK.
Department of Computer Science, University of Tartu, 18 Narva St, Tartu, Estonia.

Kosuke Yusa (K)

Institute for Frontier Life and Medical Sciences, Kyoto University, Kyoto, 606-8507, Japan.

Mathew J Garnett (MJ)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK. mg12@sanger.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH